ACTU vs AMCR · $49.0M cap vs P/E 18, rev $23.51B
Actuate Therapeutics, Inc. Common stock (ACTU) versus Amcor PLC (AMCR) — a side-by-side from cached financials, not a winner call.
Actuate Therapeutics, Inc. Common stock (ACTU) is a biotechnology company listed on NASDAQ.
Amcor PLC (AMCR) is a packaging & containers company listed on US.
ACTU does not have a complete income-statement cache yet.
Latest reported AMCR revenue for 2026-06-30 was $23.51B. Net income was $1.11B. Revenue was up 362.5% from 2025-06-30 to 2026-06-30. AMCR currently screens at market cap $22.52B and trailing P/E 17.6.
ACTU currently screens at market cap $49.0M. AMCR currently screens at market cap $22.52B and trailing P/E 17.6.
Not investment advice. Open the ACTU and AMCR stock pages for the full models.
Not investment advice.